Much ado about nothing? Discrepancy between the available data on the antiviral effect of hydroxychloroquine in March 2020 and its inclusion in COVID-19 clinical trials and outpatient prescriptions

N. Vieux, Q. Perrier, P. Bedouch, O. Epaulard

Open source

DOI
10.1016/j.puhe.2023.09.018
Published
2023-12
Container
Public Health
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.puhe.2023.09.018,
  title = {Much ado about nothing? Discrepancy between the available data on the antiviral effect of hydroxychloroquine in March 2020 and its inclusion in COVID-19 clinical trials and outpatient prescriptions},
  author = {N. Vieux and Q. Perrier and P. Bedouch and O. Epaulard},
  year = {2023},
  journal = {Public Health},
  doi = {10.1016/j.puhe.2023.09.018},
  url = {https://doi.org/10.1016/j.puhe.2023.09.018}
}

RIS

TY  - JOUR
TI  - Much ado about nothing? Discrepancy between the available data on the antiviral effect of hydroxychloroquine in March 2020 and its inclusion in COVID-19 clinical trials and outpatient prescriptions
AU  - N. Vieux
AU  - Q. Perrier
AU  - P. Bedouch
AU  - O. Epaulard
PY  - 2023
JO  - Public Health
DO  - 10.1016/j.puhe.2023.09.018
UR  - https://doi.org/10.1016/j.puhe.2023.09.018
ER  - 

APA

Vieux, N., Perrier, Q., Bedouch, P., & Epaulard, O. (2023). Much ado about nothing? Discrepancy between the available data on the antiviral effect of hydroxychloroquine in March 2020 and its inclusion in COVID-19 clinical trials and outpatient prescriptions. Public Health. https://doi.org/10.1016/j.puhe.2023.09.018

Source records